Search Results for "inhibitor"

GA in Practice

A panel of experts review real-world GA cases, imaging pearls, and practical guidance on starting complement inhibition earlier.

A Novel RASP Inhibitor for the Treatment of Dry Eye Disease

Neda Shamie, MD; and John Sheppard, MD

Take-Home Points for APL-2

David S. Boyer, MD

Exploring VEGF-C and -D Inhibition

Timothy L. Jackson, PhD, MB ChB, FRCOphth

Updates on a Novel Oral Therapy for DME

Joel A. Pearlman, MD, PhD

What is EYP-1901 (DURAVYU™, (vorolanib intravitreal insert))?

Sophie Bakri, MD; Durga S. Borkar, MD, MMCi; and Jayanth Sridhar, MD

The Tough: Declining Vision in an Age Before Anti-Complement Therapy

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

What Evidence Makes EYP-1901 a Potential Treatment for Wet AMD and DME?

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

Treating DR with Axitinib

Neal S. Shah, MD

A TKI Update for Wet AMD

Carl D. Regillo, MD and R.V. Paul Chan, MD, MSc, MBA, FACS

Patient Selection for EYP-1901

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

Phase 3 Clinical Trial Results for OTX-TKI

Patricio G. Schlottmann, MD

Reinjection Criteria

Sophie Bakri, MD; Ehsan Rahimy, MD; and Lejla Vajzovic, MD

View More